◈ Nootpedia
Compact view
Research pass: medium Compound OPTIONAL-ADD LOW

Eleuthero (Siberian Ginseng)

Extended Research
◈ Extended Research ◈

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

▸ Our verdict OPTIONAL-ADD LOW

Real adaptogenic + immune-modulation evidence (Davydov 2000 review; Hartz 2004 RCT for chronic fatigue), but the modern Western evidence base is thin and overshadowed by rhodiola for the same use cases. For Dylan, low-priority OPTIONAL-ADD — V4 already covers adaptogenic ground with rhodiola. Verdict would upgrade to STRONG-CANDIDATE for immune-frequency-illness archetype or chronic fatigue presentations; remains OPTIONAL-ADD low for cognitive optimization in healthy young adults.

Research pass: medium
▸ Decision matrix by user profile Per-archetype
  • Dylan20-30, brain-priority, high cognitive workload (Dylan-archetype)
    OPTIONAL-ADD

    low. Rhodiola in V4 covers same ground better. Add only for immune-frequency-illness presentation.

  • 30-50, executive maintenance
    OPTIONAL-ADD

    Stress + immune resilience angle relevant.

  • 50+, mild cognitive decline
    OPTIONAL-ADD

    Mild benefit; not first-line.

  • Anxiety-prone
    NEUTRAL

    Less anxiolytic than ashwagandha or theanine.

  • High athletic load, tested status
    OPTIONAL-ADD

    Russian sports-medicine tradition; not WADA-banned. Useful during high training-volume cycles.

  • Sleep-disordered
    NEUTRAL

    Mildly stimulating in some users; better as AM.

  • Recovery-focused (post-injury, post-illness)
    STRONG-CANDIDATE

    Immune-modulation angle; chronic fatigue B-tier evidence.

  • Strength/anabolic-focused
    OPTIONAL-ADD

    Endurance angle; not anabolic.

  • Frequent-illness phenotype
    STRONG-CANDIDATE

    The most defensible use case.

▸ Subjective experience (deep)
  • Onset over 2-4 weeks of consistent dosing
  • More subtle than rhodiola (less stimulating)
  • Described as "stress floor" effect — same demands, less depleting
  • No noticeable mood lift or focus sharpening
  • Some users report nothing — placebo proportion high
▸ Tolerance + cycling deep dive
  • Tolerance: Minimal
  • Recommended cycle: 4-6 weeks on, 2 weeks off (Russian classical pattern)
  • Reset protocol: 2-4 weeks off
▸ Stacking deep dive

Synergistic with

  • rhodiola (Dylan's V4): Both are classical Russian adaptogens; rhodiola is more stimulating, eleuthero more immune-skewed
  • schisandra: Russian "ADAPT-232" three-adaptogen combo
  • panax-ginseng: Compound adaptogen approach but increases stim-like signal
  • vitamin C (Dylan's V4): Immune support compound stack

Avoid stacking with

  • Other CNS stimulants at high doses: Mild additive sympathomimetic
  • Anticoagulants (warfarin): Theoretical interaction; case reports

Neutral / safe co-administration

Most V4/V5 stack compounds.

▸ Drug interactions deep dive
  • Anticoagulants (warfarin): Case report of altered INR with eleuthero co-administration; monitor
  • Digoxin: Case report of falsely elevated digoxin levels (assay interference rather than pharmacological); monitor if on cardiac glycoside
  • Diabetes medications: Mild hypoglycemia at high doses; monitor
  • Sedatives: Theoretical interaction in either direction
  • CYP enzymes: Mild CYP3A4 induction reported; less than schisandra
▸ Pharmacogenomics

Not characterized. No actionable variants known.

▸ Sourcing deep dive
Path Vendor Cost Reliability Notes
OTC capsules NOW Foods Eleuthero 500 mg ~$8-12 / 100 caps high Cheapest reliable
OTC capsules Nature's Way Eleuthero ~$10-15 / 90 caps medium-high Standard pick
OTC capsules Gaia Eleuthero ~$20-25 / 60 caps high Premium liquid-extract phyto-cap
Liquid extract Herb Pharm Eleuthero ~$15-25 / 1 fl oz high Russian-style preparation
Standardized extract Paradise Herbs Imperial Eleuthero ~$25-35 high Premium standardization
▸ Biomarkers to track (deep)
  • Baseline: AM cortisol, hsCRP, CBC with differential, fatigue scale (FAS or Chalder)
  • During use: Same panel at 8-12 weeks
  • Post-cycle: Confirm sustained or rebound
▸ Controversies / open debates Live debate
  • Eleuthero vs Panax ginseng confusion: Often conflated in literature and labels. Different genera, different pharmacology. Eleuthero is more adaptogenic-immune; Panax is more stimulant-cognitive.
  • Adaptogen category validity: Modern Western pharmacology skeptical of "adaptogen" as crisp pharmacological category; Russian/Chinese pharmacopeia treats it as established.
  • Quality control variability: Generic "Siberian ginseng" products often have low or no measurable eleutheroside content. Standardization matters.
  • Soviet trial methodology: Much of the historical evidence base is from non-blinded Soviet-era sport-medicine trials of variable rigor.
▸ Verdict change log
  • 2026-05-06 — Initial verdict: OPTIONAL-ADD (LOW confidence). For Dylan, redundant with V4 rhodiola for adaptogen ground. Useful for immune support if recurrent infection becomes an issue.
▸ Open questions / gaps Open
  • Modern Western RCT in healthy adults for adaptogen claim
  • Direct head-to-head with rhodiola for fatigue endpoints
  • Optimal eleutheroside profile and dose
  • Long-term safety beyond 6 months in healthy adults
▸ Sources (full, with our context)
Back to compact view